Allarity Therapeutics, Inc.

US$0.96As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALLRHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (96.31%)
Div yield —
ROE (157.09%)
Biotechnology
Beta (5Y) 0.57
PE TTM —
TSR TTM (33.46%)
Mkt cap US$15.35M
ROIC (34.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.19
23.00%
(55.00%)
Hold 12|11|7|10|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
18.31%
26.71%
26.26%
22.79%
Revenue$M
0.751
0.771
0.761
0.745
7.40%
5.59%
5.62%
(0.44%)
Peers (US$15.35M)
Cap (US$)
PE
15.57M
—
15.10M
0.082x
Capital
TTM
5Y
10Y
Leveragex
0.212
(0.052)
(0.053)
EBIT/Intx
1.687
0.228
0.203
Own earn%
18.59
117.59
126.65
Sh yield%
23.26
34.07
33.36
Owners
Insiders/Inst%
14.92
47.94
Short interest%
4.92
SBC / revenue%
1.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
15–24
$1 testx
—
Incr. ROIC%
55